Procyon Advisors, LLC Amicus Therapeutics, Inc. Transaction History
Procyon Advisors, LLC
- $1.54 Billion
- Q4 2024
A detailed history of Procyon Advisors, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Procyon Advisors, LLC holds 24,392 shares of FOLD stock, worth $205,624. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,392
Previous 24,647
1.03%
Holding current value
$205,624
Previous $263,000
12.93%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
311Shares Held
283MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$247 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$205 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$204 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$195 Million3.18% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$131 Million0.38% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.36B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...